VCAM1 and type 2 diabetes mellitus: On the contrary, our group showed no impairment in the capability of HDLs to inhibit VCAM-1 and ICAM-1 expression in patients with T2D, despite classical alterations in HDL lipid composition such as triglyceride enrichment and esterified cholesterol depletion [72].